David Weiland

870 citations
17 papers · 651 · h-index 10

Impact in

Papers in

    • Peroxisome Proliferator-Activated Receptors 3
    • Heme Oxygenase-1 and Carbon Monoxide 2
    • Liver Disease Diagnosis and Treatment 2

David Weiland

15 papers receiving 623 citations

Peers

David Weiland
Comparison fields: 5 of 93
  • Applied Microbiology and Biotechnology 37
  • Agronomy and Crop Science 90
  • Equine 12
  • Biochemistry 44
  • Endocrinology, Diabetes and Metabolism 78
Replace Marefat Ghaffari Novin with:
Marefat Ghaffari Novin Iran
Mark A. Cuff United Kingdom
Ken B. Hosie United Kingdom
Joëlle Henry-Berger France
Janine Keller Germany
Semone B. Myrie Canada
Ashfaqul Hoque Australia
L.M. Kuitert United Kingdom
Jason E. Elliott Canada
Rajes Qvist Malaysia
David Weiland relative to Marefat Ghaffari Novin Iran Marefat Ghaffari Novin's profile →
Citations per field
00.5×2×4×6.2×
Marefat Ghaffari Novin · 1×
Citations per year

Countries citing papers authored by David Weiland

Since Specialization
Citations

This map shows the geographic impact of David Weiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Weiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Weiland more than expected).

Fields of papers citing papers by David Weiland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Weiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Weiland. The network helps show where David Weiland may publish in the future.

Co-authors

The 25 scholars most cited alongside David Weiland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Weiland Line = papers co-authored together David Weiland links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 1987159
2 200591
3 198585
4 198675
5 201555
6 199854
7 201948
8 198040
9 200318
10 200713
11 19798
12 20102
13 20161
14 20011
15
Treatment recommendations for patients with common respiratory tract infections with variables indicative of treatment failure.
20081
16
Community-acquired bacterial respiratory tract infections.
20050
17 19870

About David Weiland

David Weiland is a scholar working on Molecular Biology, Epidemiology, Surgery, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 651 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Fatty Acid Research and Health (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), Antibiotic Use and Resistance (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Neurogenesis and neuroplasticity mechanisms (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (37 citations), Agronomy and Crop Science (90 citations), Equine (12 citations), Biochemistry (44 citations) and Endocrinology, Diabetes and Metabolism (78 citations). David Weiland has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Alan R. Tall, Ira Tabas, Robert V. Farese, L A West, Laura L. Weakland, John S. Davis, Gerald M. Reaven, C. E. Mondon, Philip R. Yarnell and Peter H. Hackett. Their work appears in journals such as Proceedings of the National Academy of Sciences, Diabetologia, Neurobiology of Disease, Radiology and American Journal of Neuroradiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact